OCON Therapeutics. Our mission is to introduce an innovative, high-quality intrauterine drug-delivery technology to improve and impact women's health and quality of life.
No named decision-maker yet.
Careers mailbox is known
Hawkeye Systems is a technology holding company focused on crypto, blockchain and digital assets, financial services, and emerging technologies, with main business lines in private equity and corporate advisory.
No named decision-maker yet.
Careers mailbox is known
Antiostherapeutics.com 403 Forbidden Unfortunately, you do not have permission to view this.
Gregory Mayes · Executive Officer, Director · decision-maker
Tamra Adams · Executive Officer · decision-maker
Idean Marvasty · Executive Officer · decision-maker
Douglas Mayers · Executive Officer · decision-maker
No careers mailbox known
Nov 2, 2021
Raised a round Series B $75M · SEC Form D
2018
Founded
Sweetch empowers B2B2C partners like Abbott, Dexcom, NovoCare with AI-driven CGM support for Blood Sugar, Type 2 Diabetes management through real-time insights.
No named decision-maker yet.
No careers mailbox known
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Jonathan Silverstein · Director · decision-maker
James Sullivan · Executive Officer, Director · decision-maker
Viola Meehan · Executive Officer · decision-maker
Uya Chuluunbaatar · Director
Careers mailbox is known
Feb 15, 2024
Raised a round Venture round $45M · SEC Form D
2019
Founded
Targeting RyR. A novel mechanism to correct calcium channel dysfunction.
No named decision-maker yet.
Careers mailbox is known
2024
Founded
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer. The company was founded by the previous founders of Emergence Therapeutics.
No named decision-maker yet.
Careers mailbox is known
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
No named decision-maker yet.
Careers mailbox is known
Sep 26
Moved to Teamtailor
Sep 23
New executive ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor · markets.businessinsider.com
Leading the future of targeted therapies for the hardest to treat cancers. Wednesday, October 15, 202512:00 pm ET.
No named decision-maker yet.
Careers mailbox is known
Jul 6
Raised a round Series D $67.4M
Aug 11, 2024
New executive FORE Biotherapeutics Names Michael Byrnes as Chief Financial Officer · businesswire.com
Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
Richard Motschwiller · Executive Officer · decision-maker
John Martin · Executive Officer, Director · decision-maker
David de Graaf · Executive Officer, Director · decision-maker
Evan Thompson · Executive Officer · decision-maker
No careers mailbox known
2025
Team of 55 was 40 · US Form 5500 (plan participants)
Feb 7, 2025
Raised a round Venture round $80M · SEC Form D
2015
Founded
Follow us on our mission to treat fibrosis and restore organ function in multiple therapeutic areas.
No named decision-maker yet.
Careers mailbox is known
2017
Founded
